Cannasouth and Eqalis' $48.8m 'merger' plans

Cannasouth and Eqalis' $48.8m 'merger' plans
Mark Lucas says it eliminates cost duplication at both firms. (Image: NZME)
Staff reporters
Cannasouth dropped 5% to 28.5 cents after the medicinal cannabis firm said it would pay $48.8 million for Equalis Pharmaceuticals in an all-scrip deal. It would also seek to raise another $9m to fund the enlarged group's working capital.The NZ stock exchange listed firm, based in Waikato, said it would issue 147.9m new Cannasouth shares at an issue price of 33c, doubling the number of shares on issue, and describing the transaction as a 'merger of equals'.Bay of Plenty-based Eqalis, founded in 2019, brings on board its capacity...

More Health

Funding sought for new real-time prostate cancer diagnostic technology
Health

Funding sought for new real-time prostate cancer diagnostic technology

As NZ trials start, researchers are already looking towards the huge US market.

Food packaging exposing us to microplastics in surprising ways
Health

Food packaging exposing us to microplastics in surprising ways

Highest number of particles that researchers found were in glass bottles.

Radius Care shrugs off aged care ‘crisis’
Markets

Radius Care shrugs off aged care ‘crisis’

Listed retirement providers are reducing their exposure to aged care. 

Gregor Thompson 23 Jun 2025
Mainland Capital delivers $50m raise for Chch hospital expansion
Finance

Mainland Capital delivers $50m raise for Chch hospital expansion

The oversubscribed raise will help fund a new state-of-the-art private hospital facility.

Oliver Lewis 13 Jun 2025